This inventor holds 1 USPTO granted patent. Top assignee: Meiji Seika Kaisha, Ltd.. Active years: 1980.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1980
Title: Zenichiro Ohya: Innovator in Antiviral Treatments
Introduction
Zenichiro Ohya is a notable inventor based in Yokohama, Japan. He has made significant contributions to the field of antiviral agents, focusing on innovative treatments for viral infections. His work is particularly relevant in today's world, where the need for effective antiviral solutions is paramount.
Latest Patents
Zenichiro Ohya holds a patent for an antiviral agent and treatment of viral infections. This groundbreaking patent introduces a new antiviral agent that contains as the active ingredient at least one known glycine derivative. The formula includes various groups that enhance its effectiveness against diseases caused by different types of viruses. This antiviral agent is designed for therapeutic prevention and treatment, showcasing Ohya's commitment to advancing medical science.
Career Highlights
Ohya is associated with Meiji Seika Kaisha, Ltd., a company known for its dedication to pharmaceutical innovations. His work at this esteemed organization has allowed him to focus on developing solutions that address pressing health challenges. With a patent portfolio that includes 1 patent, Ohya has established himself as a key figure in the field of antiviral research.
Collaborations
Throughout his career, Zenichiro Ohya has collaborated with talented individuals such as Harumi Fukuyasu and Katsuo Kawakami. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Zenichiro Ohya's contributions to antiviral treatments highlight his role as an important inventor in the pharmaceutical industry. His innovative approaches and dedication to research continue to pave the way for advancements in medical treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
